Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9089461ee71353d9df911820ff129558 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 |
filingDate |
1992-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a3dd4abdd61b47eac9be5d57ab0b42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8509b93457a0372a3043f1b93f4d77a |
publicationDate |
1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5595734-A |
titleOfInvention |
Compositions comprising ONCONASE (tm) and lovastatin |
abstract |
A pharmaceutical known by the trademark ONCONASE, as described in pending commonly owned application application number 07/436,141 filed Nov. 13, 1989, is combined with two forms of another drug known as Lovastatin. The combination of ONCONASE with Lovastatin has unexpected bioactivity in vitro against ASPC-1 human pancreatic adenocarcinoma cells, A-549 human lung carcinoma cells and HT-520 human squamous cell lung carcinoma cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003203836-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101619316-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101775400-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040334-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5728805-A |
priorityDate |
1988-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |